News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
David S. Miller: Why Cisplatin should not be added to radiotherapy for certain recurrent Endometrial Cancer
Photo taken from David Scott Miller/X
Jul 20, 2024, 22:54

David S. Miller: Why Cisplatin should not be added to radiotherapy for certain recurrent Endometrial Cancer

David Scott Miller, Gynaecologic Oncologist and Professor at Department of Obstetrics and Gynaecology at UT Southwestern Medical Center, shared a post on X about a recent paper by Ann H.Klopp et al., commenting:

“More on the results of NRG Oncology, The GOG Foundation Inc. 238, Why Cisplatin should not be added to radiotherapy for certain recurrent Endometrial Cancer. Now in print in Journal of Clinical Oncology. From International Journal of Gynaecological Cancer.”

“Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial”

Journal: ASCO Publications.

Authors: Ann H. Klopp, Danielle Enserro, Matthew Powell, Marcus Randall, Julian C. Schink, Robert S. Mannel, Laura Holman, David Bender, Christina L. Kushnir, Floor Backes, Susan L. Zweizig, Steven Waggoner, Kristin A. Bradley, Lana DeSouza Lawrence, Parviz Hanjani,Christopher J. Darus, William Small Jr., Higinia R. Cardenes, Jonathan M. Feddock, David S. Miller.

David Scott Miller

Additional information
Source: David Scott Miller/X

Ann H. Klopp cancer Cisplatin Danielle Enserro David Scott Miller Endometrial cancer International Journal of Gynaecological Cancer Jonathan M. Feddock Journal of Clinical Oncology Matthew Powell NRG Oncology OncoDaily Oncology radiotherapy The GOG Foundation Inc. UT Southwestern Medical Center
Special Coverage
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center
Blog
Nov 13, 2024, 10:16
Highlights from IU Simon Comprehensive Cancer Center’s End Lung Cancer Now Gathering - Hoosier Cancer Research Network
Blog
Nov 13, 2024, 10:06
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program